Wilderness Medical Society Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update

Andrew M. Luks, Paul S. Auerbach, Luanne Freer, Colin K. Grissom, Linda E. Keyes, Scott E. McIntosh, George W Rodway, Robert B. Schoene, Ken Zafren, Peter H. Hackett

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

To provide guidance to clinicians about best preventive and therapeutic practices, the Wilderness Medical Society (WMS) convened an expert panel to develop evidence-based guidelines for prevention and treatment of acute mountain sickness, high altitude cerebral edema, and high altitude pulmonary edema. Recommendations are graded based on the quality of supporting evidence and the balance between the benefits and risks/burdens according to criteria put forth by the American College of Chest Physicians. The guidelines also provide suggested approaches to prevention and management of each form of acute altitude illness that incorporate these recommendations. This is an updated version of the original WMS Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness published in 2010 and subsequently updated as the WMS Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness in 2014.

Original languageEnglish (US)
JournalWilderness and Environmental Medicine
DOIs
StatePublished - Jan 1 2019

Keywords

  • acetazolamide
  • acute mountain sickness
  • dexamethasone
  • high altitude
  • high altitude cerebral edema
  • high altitude pulmonary edema
  • nifedipine

ASJC Scopus subject areas

  • Emergency Medicine
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'Wilderness Medical Society Practice Guidelines for the Prevention and Treatment of Acute Altitude Illness: 2019 Update'. Together they form a unique fingerprint.

Cite this